Pasar al contenido principal

CONTROL DE LA HETEROGENEIDAD Y EVASION INMUNE TUMORAL POR LA MECANICA TISULAR Y LA GENERACION DE FUERZAS INTRACELULARES

SAF2017-87408-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación

Phosphatidylinositol monophosphates regulate optimal Vav1 signaling output

  • Rodríguez-Fdez, Sonia
  • Citterio, Carmen
  • Lorenzo-Martín, L. Francisco
  • Baltanás-Copado, Jesús
  • Llorente-González, Clara
  • Corbalán-García, Senena
  • Vicente-Manzanares, Miguel
  • Bustelo, Xosé R.
Phosphatidylinositol–5 phosphate (PI5P) and other mono-phosphoinositides (mono-PIs) play second messenger roles in both physiological and pathological conditions. Despite this, their intracellular targets and mechanisms of action remain poorly characterized. Here, we show that Vav1, a protein that exhibits both Rac1 GDP/GTP exchange and adaptor activities, is positively modulated by PI5P and, possibly, other mono-PIs. Unlike other phospholipid–protein complexes, the affinity and specificity of the Vav1–lipid interaction entail a new structural solution that involves the synergistic action of the Vav1 C1 domain and an adjacent polybasic tail. This new regulatory layer, which is not conserved in the Vav family paralogs, favors the engagement of optimal Vav1 signaling outputs in lymphocytes., X.R.B. is supported by grants from the Castilla–León Government (CSI049U16, CLC–2017–01); the Spanish Ministry of Science, Innovation, and Universities (MSIU) (SAF2015–64556–R, RTI2018–096481–B–I00); and the Spanish Association against Cancer (GC16173472GARC). X.R.B.’s institution is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia of the Ministry of Education of the Castilla–León Government (CLC–2017–01). S.C.-G. is supported by grants from MISIU (BFU2017–87222–P) and Séneca Región de Murcia Foundation (19409/PI/14). M.V.-M. is supported by grants from the MISIU (SAF2017–87408–R) and the Spanish Association against Cancer (2018–IDEAS18018VICE). S.R.-F.’s and L.F.L.-M.’s contracts were supported by funding from the MISIU (SR-F, BES–2013–063573) and the Spanish Ministry of Education, Culture, and Sports (LFL–M, FPU13/02923), respectively. Both Spanish and Castilla–León government-associated funding is partially supported by the European Regional Development Fund., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Linking the landscape of MYH9-related diseases to the molecular mechanisms that control non-muscle myosin II-A function in cells

  • Asensio-Juárez, Gloria
  • Llorente-González, Clara
  • Vicente-Manzanares, Miguel
This article belongs to the Special Issue Actin-Myosin Cytoskeleton Regulation and Function., The MYH9 gene encodes the heavy chain (MHCII) of non-muscle myosin II A (NMII-A). This is an actin-binding molecular motor essential for development that participates in many crucial cellular processes such as adhesion, cell migration, cytokinesis and polarization, maintenance of cell shape and signal transduction. Several types of mutations in the MYH9 gene cause an array of autosomal dominant disorders, globally known as MYH9-related diseases (MYH9-RD). These include May-Hegglin anomaly (MHA), Epstein syndrome (EPS), Fechtner syndrome (FTS) and Sebastian platelet syndrome (SPS). Although caused by different MYH9 mutations, all patients present macrothrombocytopenia, but may later display other pathologies, including loss of hearing, renal failure and presenile cataracts. The correlation between the molecular and cellular effects of the different mutations and clinical presentation are beginning to be established. In this review, we correlate the defects that MYH9 mutations cause at a molecular and cellular level (for example, deficient filament formation, altered ATPase activity or actin-binding) with the clinical presentation of the syndromes in human patients. We address why these syndromes are tissue restricted, and the existence of possible compensatory mechanisms, including residual activity of mutant NMII-A and/or the formation of heteropolymers or co-polymers with other NMII isoforms., This Perspective is based on research funded by Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia (CLC–2017–01) from the Castilla–León government and FEDER funds; SAF2014-54705-R and SAF2017-87408-R from MINECO; CIVP16A1831 from the Ramón Areces Foundation, 14-BBM-340 from the BBVA Foundation and IDEAS-VICE18 from the AECC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tyrosine phosphorylation of the myosin regulatory light chain controls non-muscle myosin II assembly and function in migrating cells

  • Aguilar-Cuenca, Rocio
  • Llorente-González, Clara
  • Chapman, Jessica R.
  • Talayero, Vanessa C.
  • Garrido-Casado, Marina
  • Delgado Arévalo, Cristina
  • Millán-Salanova, María
  • Shabanowitz, Jeffrey
  • Hunt, Donald F.
  • Sellers, James R.
  • Heissler, Sarah M.
  • Vicente-Manzanares, Miguel
Active non-muscle myosin II (NMII) enables migratory cell polarization and controls dynamic cellular processes, such as focal adhesion formation and turnover and cell division. Filament assembly and force generation depend on NMII activation through the phosphorylation of Ser19 of the regulatory light chain (RLC). Here, we identify amino acid Tyr (Y) 155 of the RLC as a novel regulatory site that spatially controls NMII function. We show that Y155 is phosphorylated in vitro by the Tyr kinase domain of epidermal growth factor (EGF) receptor. In cells, phosphorylation of Y155, or its phospho-mimetic mutation (Glu), prevents the interaction of RLC with the myosin heavy chain (MHCII) to form functional NMII units. Conversely, Y155 mutation to a structurally similar but non-phosphorylatable amino acid (Phe) restores the more dynamic cellular functions of NMII, such as myosin filament formation and nascent adhesion assembly, but not those requiring stable actomyosin bundles, e.g., focal adhesion elongation or migratory front-back polarization. In live cells, phospho-Y155 RLC is prominently featured in protrusions, where it prevents NMII assembly. Our data indicate that Y155 phosphorylation constitutes a novel regulatory mechanism that contributes to the compartmentalization of NMII assembly and function in live cells., C.L.-G. is supported by a predoctoral fellowship from the Junta de Castilla y León. M.M.-S. is supported by a predoctoral fellowhip from the AECC. This work was funded by the following grants: Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia (CLC–2017–01) from the Junta de Castilla-León with FEDER funds (Spain); SAF2014-54705-R and SAF2017-87408-R from MINECO (Spain); CIVP16A1831 from the Ramón Areces Foundation (Spain); 14-BBM-340 from the BBVA Foundation (Spain); and IDEAS-VICE18 from the Asociacion Española Contra el Cáncer (AECC, Spain) to M.V.-M.; NIH GM 037537 (D.F.H.); and K22HL131869 (S.M.H.) and the Intramural Research Program (J.R.S.) of the National Heart, Lung, and Blood Institute, NIH., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction

  • Soriano, Olga
  • Alcón-Pérez, Marta
  • Vicente-Manzanares, Miguel
  • Castellano, Esther
© 2021 by the authors., Ras and Rho proteins are GTP-regulated molecular switches that control multiple signaling pathways in eukaryotic cells. Ras was among the first identified oncogenes, and it appears mutated in many forms of human cancer. It mainly promotes proliferation and survival through the MAPK pathway and the PI3K/AKT pathways, respectively. However, the myriad proteins close to the plasma membrane that activate or inhibit Ras make it a major regulator of many apparently unrelated pathways. On the other hand, Rho is weakly oncogenic by itself, but it critically regulates microfilament dynamics; that is, actin polymerization, disassembly and contraction. Polymerization is driven mainly by the Arp2/3 complex and formins, whereas contraction depends on myosin mini-filament assembly and activity. These two pathways intersect at numerous points: from Ras-dependent triggering of Rho activators, some of which act through PI3K, to mechanical feedback driven by actomyosin action. Here, we describe the main points of connection between the Ras and Rho pathways as they coordinately drive oncogenic transformation. We emphasize the biochemical crosstalk that drives actomyosin contraction driven by Ras in a Rho-dependent manner. We also describe possible routes of mechanical feedback through which myosin II activation may control Ras/Rho activation., This work was funded by the Spanish Ministry of Science and Innovation (SAF2017- 87408 and RTI2018-099161-A-I00), AECC Seed award (2018–IDEAS18018VICE) and ECRIN-M3 from AECC/AIRC/CRUK. IBMCC is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia of the Ministry of Education of the Castilla–León Government (CLC–2017–01)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Adhesive Interactions Delineate the Topography of the Immune Synapse

  • Martín-Cófreces, Noa Beatriz
  • Vicente-Manzanares, Miguel
  • Sánchez-Madrid, Francisco
© 2018 Martín-Cófreces, Vicente-Manzanares and Sánchez-Madrid., T cells form adhesive contacts with antigen-presenting cells (APCs) as part of the normal surveillance process that occurs in lymph nodes and other tissues. Most of these adhesive interactions are formed by integrins that interact with ligands expressed on the surface of the APC. The interactive strength of integrins depends on their degree of membrane proximity as well as intracellular signals that dictate the conformation of the integrin. Integrins appear in different conformations that endow them with different affinities for their ligand(s). Integrin conformation and thus adhesive strength between the T cell and the APC is tuned by intracellular signals that are turned on by ligation of the T cell receptor (TCR) and chemokine receptors. During the different stages of the process, integrins, the TCR and chemokine receptors may be interconnected by the actin cytoskeleton underneath the plasma membrane, forming a chemical and physical network that facilitates the spatiotemporal dynamics, positioning, and function of these receptors and supports cell-cell adhesion during T cell activation, allowing it to perform its effector function., This manuscript has been funded by grants SAF2014-55579-R and SAF 2017-82886-R (FS-M) and SAF2014-54705-R and SAF2017-87408-R (MV-M) from the Spanish Ministry of Economy and Competitiveness; CAM S2017/BMD-3671 from the Comunidad de Madrid (FS-M); ERC-2011-AdG294340-GENTRIS (FS-M); and 2018-IDEAS18018VICE from the Asociación Española contra el Cáncer (MV-M).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An Integrated View of Virus-Triggered Cellular Plasticity Using Boolean Networks

  • Alfaro-García, Jenny Paola
  • Granados-Alzate, María Camila
  • Vicente-Manzanares, Miguel
  • Gallego-Gómez, Juan Carlos
Virus-related mortality and morbidity are due to cell/tissue damage caused by replicative pressure and resource exhaustion, e.g., HBV or HIV; exaggerated immune responses, e.g., SARS-CoV-2; and cancer, e.g., EBV or HPV. In this context, oncogenic and other types of viruses drive genetic and epigenetic changes that expand the tumorigenic program, including modifications to the ability of cancer cells to migrate. The best-characterized group of changes is collectively known as the epithelial–mesenchymal transition, or EMT. This is a complex phenomenon classically described using biochemistry, cell biology and genetics. However, these methods require enormous, often slow, efforts to identify and validate novel therapeutic targets. Systems biology can complement and accelerate discoveries in this field. One example of such an approach is Boolean networks, which make complex biological problems tractable by modeling data (“nodes”) connected by logical operators. Here, we focus on virus-induced cellular plasticity and cell reprogramming in mammals, and how Boolean networks could provide novel insights into the ability of some viruses to trigger uncontrolled cell proliferation and EMT, two key hallmarks of cancer., This research is funded by Min. Ciencias, Colombia, grant CTO 917-2019, University of Antioquia, grant CODI-2020-34137, Sustainability Program 2018-9 of CODI-UdeA, Agreement-internship for Young researchers UdeA and Exclusivity Program-UdeA, to J.C.G.-G.; and grants SAF2017- 87408-R and PID2020-116232RB-I00 (Min. Ciencia e Innovación, España) and CRUK/AIRC/AECC (ECRIN-M3), to M.V.-M., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nonmuscle Myosin II Regulation Directs Its Multiple Roles in Cell Migration and Division

  • Garrido-Casado, Marina
  • Asensio-Juárez, Gloria
  • Vicente-Manzanares, Miguel
Nonmuscle myosin II (NMII) is a multimeric protein complex that generates most mechanical force in eukaryotic cells. NMII function is controlled at three main levels. The first level includes events that trigger conformational changes that extend the complex to enable its assembly into filaments. The second level controls the ATPase activity of the complex and its binding to microfilaments in extended NMII filaments. The third level includes events that modulate the stability and contractility of the filaments. They all work in concert to finely control force generation inside cells. NMII is a common endpoint of mechanochemical signaling pathways that control cellular responses to physical and chemical extracellular cues. Specific phosphorylations modulate NMII activation in a context-dependent manner. A few kinases control these phosphorylations in a spatially, temporally, and lineage-restricted fashion, enabling functional adaptability to the cellular microenvironment. Here, we review mechanisms that control NMII activity in the context of cell migration and division., This work was funded by the Spanish Ministry of Science and Innovation (grant SAF2017–87408), an Asociación Española Contra el Cáncer (AECC) Seed award (2018–IDEAS18018VICE) and grant ECRIN-M3 from AECC/Associazione Italiana per la Ricerca sul Cancro (AIRC)/Cancer Research UK (CRUK). Instituto de Biología Molecular y Celular del Cáncer (IBMCC) is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia of the Ministry of Education of the Castilla–León Government (grant CLC–2017–01).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Targeting cytoskeletal phosphorylation in cancer

  • Llorente-González, Clara
  • González-Rodríguez, Marta
  • Vicente-Manzanares, Miguel
Phosphorylation of cytoskeletal proteins regulates the dynamics of polymerization, stability, and disassembly of the different types of cytoskeletal polymers. These control the ability of cells to migrate and divide. Mutations and alterations of the expression levels of multiple protein kinases are hallmarks of most forms of cancer. Thus, altered phosphorylation of cytoskeletal proteins is observed in most cancer cells. These alterations potentially control the ability of cancer cells to divide, invade and form distal metastasis. This review highlights the emergent role of phosphorylation in the control of the function of the different cytoskeletal polymers in cancer cells. It also addresses the potential effect of targeted inhibitors in the normalization of cytoskeletal function., This work was funded by the Spanish Ministry of Science and Innovation (SAF2017-87408), AECC Seed award (2018-IDEAS18018VICE) and ECRIN-M3 from AECC/AIRC/CRUK. IBMCC is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia of the Ministry of Education of the Castilla-León Government (CLC-2017-01).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Myosin II proteins are required for organization of calcium-induced actin networks upstream of mitochondrial division

  • Kage, Frieda
  • Vicente-Manzanares, Miguel
  • McEwan, Brennan C.
  • Kettenbach, Arminja N.
  • Higgs, Henry N.
The formin INF2 polymerizes a calcium-activated cytoplasmic network of actin filaments, which we refer to as calcium-induced actin polymerization (CIA). CIA plays important roles in multiple cellular processes, including mitochondrial dynamics and vesicle transport. Here, we show that nonmuscle myosin II (NMII) is activated within 60 s of calcium stimulation and rapidly recruited to the CIA network. Knockout of any individual NMII in U2OS cells affects the organization of the CIA network, as well as three downstream effects: endoplasmic-reticulum-to-mitochondrial calcium transfer, mitochondrial Drp1 recruitment, and mitochondrial division. Interestingly, while NMIIC is the least abundant NMII in U2OS cells (>200-fold less than NMIIA and >10-fold less than NMIIB), its knockout is equally deleterious to CIA. On the basis of these results, we propose that myosin II filaments containing all three NMII heavy chains exert organizational and contractile roles in the CIA network. In addition, NMIIA knockout causes a significant decrease in myosin regulatory light chain levels, which might have additional effects., This work was supported by National Institutes of Health (NIH) R35 GM122545 and R01 DK088826 to H.N.H., NIH P20 GM113132 to the Dartmouth BioMT, and Deutsche Forschungs-gemeinschaft (DFG) fellowship KA5106/1-1 to F. K. M.V.-M. acknowledges funding from the Spanish Ministry of Science and Innovation (SAF2017-87408 and PID2020-116232RB-I00) and ECRIN-M3 from AECC/AIRC/CRUK (Asociation Espanola Contra el Cancer/American International Recruitment Council/Cancer Research UK). The IBMCC (Institute of Molecular and Cell Biology of Cancer) is supported by the Programa e Apoyo a Planes Estrategicos de Investigacion de Estructuras de Investigacion de Excelencia of the Ministry of Education of the Castilla-Leon Government (CLC-2017-01). This work was also supported by NIH R35 GM119455 to A.N.K.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The interface between biochemical signaling and cell mechanics shapes T lymphocyte migration and activation

  • Millán-Salanova, María
  • Vicente-Manzanares, Miguel
tT cells migrate to lymphoid organs to become activated through specific contacts with antigen-presenting cells bearing foreign antigens. During migration and activation, T lymphocytes are exposed not only to diverse biochemical inputs, but also to different mechanical conditions. Passage from the blood or lymph to solid tissues involves lymphocyte rolling, firm arrest and diapedesis through endothelial monolayers. Throughout this process, cells are subjected to diverse fluid flow regimes. After extravasation, T lymphocytes crawl through viscoelastic media of different biochemical and mechanical properties and geometries. In lymph nodes, T cell contact with antigen-presenting cells is guided by rigidity cues and ligand-receptor interactions. T lymphocyte adaptation to diverse mechanical regimes involves multiple signaling and morphological modifications, many of which enable the conversion of mechanical forces into biochemical signals and vice-versa. These components enable T lymphocyte survival, homing and activation. Here, we review the mechanisms that enable T lymphocytes to survive and thrive under the different mechanical conditions they encounter during their life cycle. These processes require the integration of diverse signaling networks that convert extracellular mechano-chemical cues into force, movement and activation., M.M-S. is supported by an AECC PhD fellowship. M.V-M. acknowledges funding of Min. Ciencia e Innovación, España (grants SAF2017-87408-R and PID2020-116232RB-I00) and Cancer Research UK/ Fondazione AIRC per la Ricerca sul Cancro, Italia/ Asociacion Española contra el Cáncer, España (Accelerator award ECRIN-M3, 2020).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Chapter 15 - Cancer cell development, migratory response, and the role of the tumor microenvironment in invasion and metastasis

  • Antón, Inés María
  • Wandosell, Francisco
  • Vicente-Manzanares, Miguel
Acquisition of motile capability is one of the most tantalizing features of the oncogenic cell transformation program. Cancer cell migration borrows heavily from normal morphogenetic processes that are activated during embryonic differentiation and tissue growth. Tumor cell migration is triggered by genetic modifications that activate transcriptional programs, e.g., the epithelial–mesenchymal transition, which lie dormant in healthy tissues. These programs allow cells to generate structures that enable them to move and manipulate the extracellular matrix to favor their dissemination, e.g., invadopodia. Collectively, these processes not only affect the cancer cells themselves, but also trigger modifications of the tumor microenvironment, aggressively promoting tumor growth and dissemination. As such, cancer cell migration not only depends on the genetic changes that are the most important element of oncogenic transformation; but it is also influenced by the mechanochemical makeup of the tumor microenvironment. In this chapter, we describe the changes that enable tumor cells to become migratory. We also address the cellular and acellular composition of the tumor microenvironment as it controls cancer growth and migration, from small tumors made of a few cells to large, invasive masses that have the ability to form distal metastasis., IMA and FW acknowledge funding from the Fundación Ramón Areces (CIVP18A3861) and Spanish Ministry of Science and Innovation (RTI2018-096303-B-C31), which was in part granted with FEDER funding (EC), corresponding to the Programa Estatal de Investigación, Desarrollo e Innovación Orientada a los Retos de la Sociedad. M-VM acknowledges funding from the Spanish Ministry of Science and Innovation (SAF2017-87408, PID2020-116232-PB-I00), AECC Seed award (2018–IDEAS18018VICE), and ECRIN-M3 from AECC/AIRC/CRUK. IBMCC is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia of the Ministry of Education of the Castilla–León Government (CLC–2017–01).